$BRKR
BRUKER CORP Stock $brkr

$brkr Overview Financials Valuation SEC Filings Company Website

2012 Q2 Form 10-Q Financial Statement

#000110465912056040 Filed on August 09, 2012

Income Statement

Concept	2012 Q2	2011 Q2
Revenue	$420.7M	$401.2M
YoY Change	4.86%	33.33%
Cost Of Revenue	$232.5M	$217.6M
YoY Change	6.85%	31.4%
Gross Profit	$187.7M	$183.6M
YoY Change	2.23%	35.7%
Gross Profit Margin	44.62%	45.76%
Selling, General & Admin	$110.6M	$98.20M
YoY Change	12.63%	53.44%
% of Gross Profit	58.92%	53.49%
Research & Development	$51.90M	$44.30M
YoY Change	17.16%	41.99%
% of Gross Profit	27.65%	24.13%
Depreciation & Amortization	$15.00M	$13.80M
YoY Change	8.7%	91.67%
% of Gross Profit	7.99%	7.52%
Operating Expenses	$166.1M	$144.9M
YoY Change	14.63%	51.73%
Operating Profit	$22.10M	$38.70M
YoY Change	-42.89%	-2.76%
Interest Expense	$3.500M	$1.600M
YoY Change	118.75%	-145.71%
% of Operating Profit	15.84%	4.13%
Other Income/Expense, Net	-$2.800M	-$500.0K
YoY Change	460.0%	-28.57%
Pretax Income	$19.30M	$33.00M
YoY Change	-41.52%	-2.08%
Income Tax	$9.400M	$10.40M
% Of Pretax Income	48.7%	31.52%
Net Earnings	$9.900M	$22.10M
YoY Change	-55.2%	-2.21%
Net Earnings / Revenue	2.35%	5.51%
Basic Earnings Per Share	$0.06	$0.13
Diluted Earnings Per Share	$0.06	$0.13
COMMON SHARES
Basic Shares Outstanding	166.0M shares	165.4M shares
Diluted Shares Outstanding	167.1M shares

Balance Sheet

Concept	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$240.3M	$169.8M
YoY Change	41.52%	-9.49%
Cash & Equivalents	$240.3M	$169.8M
Short-Term Investments
Other Short-Term Assets	$102.7M	$104.9M
YoY Change	-2.1%	71.97%
Inventory	$620.3M	$618.7M
Prepaid Expenses
Receivables	$248.8M	$273.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.212B	$1.167B
YoY Change	3.86%	39.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$259.1M	$265.9M
YoY Change	-2.56%	33.42%
Goodwill	$109.8M
YoY Change
Intangibles	$138.5M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.60M	$29.20M
YoY Change	4.79%
Total Long-Term Assets	$538.0M	$532.8M
YoY Change	0.98%	74.17%
TOTAL ASSETS
Total Short-Term Assets	$1.212B	$1.167B
Total Long-Term Assets	$538.0M	$532.8M
Total Assets	$1.750B	$1.700B
YoY Change	2.95%	49.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.40M	$82.00M
YoY Change	-5.61%	52.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$185.5M
YoY Change	-100.0%
Long-Term Debt Due	$77.60M	$42.10M
YoY Change	84.32%	67.73%
Total Short-Term Liabilities	$751.9M	$901.7M
YoY Change	-16.61%	66.0%
LONG-TERM LIABILITIES
Long-Term Debt	$243.3M	$60.20M
YoY Change	304.15%	-40.75%
Other Long-Term Liabilities	$113.3M	$107.2M
YoY Change	5.69%	29.0%
Total Long-Term Liabilities	$356.6M	$167.4M
YoY Change	113.02%	-9.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$751.9M	$901.7M
Total Long-Term Liabilities	$356.6M	$167.4M
Total Liabilities	$1.111B	$1.073B
YoY Change	3.63%	47.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	20.83K shares
Shareholders Equity	$638.7M	$627.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.750B	$1.700B
YoY Change	2.95%	49.05%

Cashflow Statement

Concept	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	$9.900M	$22.10M
YoY Change	-55.2%	-2.21%
Depreciation, Depletion And Amortization	$15.00M	$13.80M
YoY Change	8.7%	91.67%
Cash From Operating Activities	$37.10M	$3.800M
YoY Change	876.32%	-92.02%
INVESTING ACTIVITIES
Capital Expenditures	-$18.80M	-$21.30M
YoY Change	-11.74%	301.89%
Acquisitions
YoY Change
Other Investing Activities	$900.0K	-$1.100M
YoY Change	-181.82%	-97.09%
Cash From Investing Activities	-$17.90M	-$22.40M
YoY Change	-20.09%	-48.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.700M	-9.900M
YoY Change	-127.27%	115.22%
NET CHANGE
Cash From Operating Activities	37.10M	3.800M
Cash From Investing Activities	-17.90M	-22.40M
Cash From Financing Activities	2.700M	-9.900M
Net Change In Cash	21.90M	-28.50M
YoY Change	-176.84%	28400.0%
FREE CASH FLOW
Cash From Operating Activities	$37.10M	$3.800M
Capital Expenditures	-$18.80M	-$21.30M
Free Cash Flow	$55.90M	$25.10M
YoY Change	122.71%	-52.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	246000000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	282800000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	576200000	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	89100000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	1194100000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	249000000	USD
CY2011Q4	brkr	Intangibles And Other Long Term Assets Noncurrent IntangiblesAndOtherLongTermAssetsNoncurrent	267400000	USD
CY2011Q4	us-gaap	Assets Assets	1710500000	USD
CY2011Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	83700000	USD
CY2011Q2	brkr	Demonstration Inventory Write Down DemonstrationInventoryWriteDown	7100000	USD
	brkr	Demonstration Inventory Write Down DemonstrationInventoryWriteDown	13600000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89000000	USD
	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	4500000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	72300000	USD
CY2011Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	268600000	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	751900000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	638700000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	331200000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	755800000	USD
CY2011Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	219400000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	110400000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1700000	USD
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	200000	USD
CY2011Q4	brkr	Others Shareholders Equity OthersShareholdersEquity	178500000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	621500000	USD
CY2011Q4	us-gaap	Minority Interest MinorityInterest	3400000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	624900000	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1710500000	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1750100000	USD
CY2012Q2	us-gaap	Assets Assets	1750100000	USD
CY2012Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	260000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	260000000	shares
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	166283596	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	165892170	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	166262767	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	165871905	shares
CY2012Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	20829	shares
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	20265	shares
CY2011Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	352100000	USD
CY2011Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	46800000	USD
CY2011Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	2300000	USD
CY2011Q2	us-gaap	Revenues Revenues	401200000	USD
CY2011Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	191700000	USD
CY2011Q2	us-gaap	Cost Of Services CostOfServices	25900000	USD
CY2011Q2	us-gaap	Cost Of Revenue CostOfRevenue	217600000	USD
CY2011Q2	us-gaap	Gross Profit GrossProfit	183600000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	664200000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	90400000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	3600000	USD
	us-gaap	Revenues Revenues	758200000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	362400000	USD
	us-gaap	Cost Of Services CostOfServices	50400000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	412800000	USD
	us-gaap	Gross Profit GrossProfit	345400000	USD
CY2011Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	98200000	USD
CY2011Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44300000	USD
CY2011Q2	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	2400000	USD
CY2011Q2	us-gaap	Operating Expenses OperatingExpenses	144900000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	187500000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2011Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	22100000	USD
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2011Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165400000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	33400000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33000000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10400000	USD
CY2011Q2	us-gaap	Profit Loss ProfitLoss	22600000	USD
CY2011Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	500000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167000000	shares
	us-gaap	Operating Expenses OperatingExpenses	281000000	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	38700000	USD
CY2011Q2	brkr	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-5700000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	64400000	USD
	brkr	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-10700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	53700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19400000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-60600000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	900000	USD
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2012Q2	us-gaap	Revenues Revenues	420700000	USD
CY2012Q2	us-gaap	Cost Of Revenue CostOfRevenue	232500000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	188200000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	166100000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19300000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9900000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	25000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	46200000	USD
	us-gaap	Operating Expenses OperatingExpenses	322100000	USD
	us-gaap	Gross Profit GrossProfit	378600000	USD
	us-gaap	Revenues Revenues	826300000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10000000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165900000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167000000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167100000	shares
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23500000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166000000	shares
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	94200000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1100000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	93100000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	54400000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	600000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	53800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-25600000	USD
	us-gaap	Profit Loss ProfitLoss	34300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25700000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	300000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	19400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3800000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4300000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-700000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	447700000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28400000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	13000000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	2900000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	11000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-32500000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1300000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-14000000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-300000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13700000	USD
CY2012Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	92400000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1200000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	82000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-14700000	USD
	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-1400000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-5700000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	400000	USD
	us-gaap	Stock Issued1 StockIssued1	2900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	41900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-50400000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	240000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	17500000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	11500000	USD
	dei	Entity Registrant Name EntityRegistrantName	BRUKER CORP
	dei	Entity Central Index Key EntityCentralIndexKey	0001109354
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	166262837	shares
	us-gaap	Nature Of Operations NatureOfOperations	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt 0.25in; TEXT-INDENT: -0.25in"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">1.</font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 3pt" size="1">              </font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt" size="2">Description of Business</font></b></p> <p style="MARGIN: 0in 0in 0pt 0.25in; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Bruker Corporation, together with its consolidated subsidiaries (‘‘Bruker’’ or the ‘‘Company’’), is a designer and manufacturer of proprietary life science and materials research systems and associated products that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company’s core technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. The Company also manufactures and distributes a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives (‘‘CBRNE’’) detection. The Company develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and ‘‘big science’’ research. The Company maintains major technical and manufacturing centers in Europe, North America and Japan, and has sales offices located throughout the world. The Company’s diverse customer base includes life science, pharmaceutical, biotechnology and molecular diagnostic research companies, academic institutions, advanced materials and semiconductor manufacturers and government agencies.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Management reports results on the basis of the following two segments:</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol" size="2">·</font><font style="FONT-SIZE: 3pt" size="1">                  </font><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic" size="2">Scientific Instruments.  </font></i><font style="FONT-SIZE: 10pt" size="2">The operations of this segment include the design, manufacture and distribution of advanced instrumentation and automated solutions based on magnetic resonance technology, mass spectrometry technology, gas chromatography technology, X-ray technology, spark-optical emission spectroscopy technology, atomic force microscopy technology, stylus and optical metrology technology, and infrared and Raman molecular spectroscopy technology.  Typical customers of the Scientific Instruments segment include: pharmaceutical, biotechnology and molecular diagnostic companies; academic institutions, medical schools and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals and petroleum companies; and food, beverage and agricultural analysis companies and laboratories.</font></p> <p style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol" size="2">·</font><font style="FONT-SIZE: 3pt" size="1">                  </font><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic" size="2">Energy & Supercon Technologies.</font></i><font style="FONT-SIZE: 10pt" size="2"> The operations of this segment include the design, manufacture and marketing of superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications, and ceramic high temperature superconductors primarily for fusion energy research applications. Typical customers of the Energy & Supercon Technologies segment include companies in the medical industry, private and public research and development laboratories in the fields of fundamental and applied sciences and energy research, academic institutions and government agencies. The Energy & Supercon Technologies segment is also developing superconductors and superconducting-enabled devices for applications in power and energy, as well as industrial processing industries.</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The unaudited condensed consolidated financial statements represent the consolidated accounts of the Company. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements as of June 30, 2012 and December 31, 2011 and for the three and six months ended June 30, 2012 and 2011, have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial information presented herein does not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation have been included. The results for interim periods are not necessarily indicative of the results expected for the full year or any other interim period.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Amortization of certain technology-related intangible assets totaling $0.7 million and $1.3 million for the three and six months ended June 30, 2011, respectively, were reclassified to selling, general and administrative expenses from amortization of acquisition-related intangible assets to conform to current year presentation.  This reclassification had no effect on previously reported net income or cash flows.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The Company has evaluated all subsequent events and determined that there are no material recognized or unrecognized subsequent events requiring disclosure.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">At June 30, 2012, the Company’s significant accounting policies and estimates, which are detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, have not changed.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr></table>
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240300000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	230400000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169800000	USD
	brkr	Reporting Segments Number ReportingSegmentsNumber	2	segment
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000	USD
CY2011Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3800000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3800000	USD
CY2012Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	200000	USD
CY2011Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	200000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	1700000	USD
CY2011Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	1800000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	3300000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	3300000	USD
CY2011Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1900000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1700000	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1100000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1100000	shares
CY2011Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.20
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.15
CY2012Q2	brkr	Demonstration Inventory Write Down DemonstrationInventoryWriteDown	7300000	USD
	brkr	Demonstration Inventory Write Down DemonstrationInventoryWriteDown	14100000	USD
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	200000	USD
CY2012Q2	us-gaap	Inventory Net InventoryNet	620300000	USD
CY2012Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	186700000	USD
CY2011Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	175300000	USD
CY2012Q2	us-gaap	Other Inventory Demo OtherInventoryDemo	60700000	USD
CY2011Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	175500000	USD
CY2011Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	169400000	USD
CY2011Q4	us-gaap	Other Inventory Demo OtherInventoryDemo	56000000	USD
CY2012Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	202000000	USD
CY2012Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	170900000	USD
CY2011Q4	us-gaap	Other Inventory In Transit OtherInventoryInTransit	116800000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	109800000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	100200000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	9900000	USD
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	-600000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-900000	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	178400000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	163600000	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	45700000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35200000	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	132700000	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	5600000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	128400000	USD
	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	10700000	USD
CY2011Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	4200000	USD
	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	8100000	USD
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	136400000	USD
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	138500000	USD
CY2012Q2	brkr	Intangible Assets Excluding Goodwill Gross IntangibleAssetsExcludingGoodwillGross	184200000	USD
CY2011Q4	brkr	Intangible Assets Excluding Goodwill Gross IntangibleAssetsExcludingGoodwillGross	171600000	USD
CY2011Q4	us-gaap	Long Term Debt LongTermDebt	303100000	USD
CY2012Q2	us-gaap	Long Term Debt LongTermDebt	320900000	USD
CY2012Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	77600000	USD
CY2012Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	243300000	USD
CY2012Q1	brkr	Number Of Consecutive Fiscal Quarters For Covenant Consolidated Interest Coverage Ratio NumberOfConsecutiveFiscalQuartersForCovenantConsolidatedInterestCoverageRatio	4	quater
CY2011	brkr	Foreign Currency Contract Typical Maturity Period Maximum ForeignCurrencyContractTypicalMaturityPeriodMaximum	12
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21200000	USD
CY2012Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.487	pure
CY2011Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.315	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.459	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.361	pure
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	35600000	USD
CY2012Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	28300000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	5600000	USD
CY2012Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	5800000	USD
CY2012Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	100000	USD
CY2011Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	200000	USD
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	400000	USD
CY2012Q2	us-gaap	Profit Loss ProfitLoss	9900000	USD
	us-gaap	Profit Loss ProfitLoss	25000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-34700000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-15900000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	33200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	61300000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-200000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-200000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-300000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-400000	USD
	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-900000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-500000	USD
	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-1000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	900000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	300000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	-1700000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	-2100000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-23500000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	10100000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	100000	USD
CY2012Q1	us-gaap	Minority Interest MinorityInterest	3500000	USD
CY2012Q2	us-gaap	Minority Interest MinorityInterest	2900000	USD
CY2011Q1	us-gaap	Minority Interest MinorityInterest	3200000	USD
CY2010Q4	us-gaap	Minority Interest MinorityInterest	2700000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	100000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	100000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	200000	USD
CY2011Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-400000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-400000	USD
CY2012Q2	us-gaap	Legal Fees LegalFees	2200000	USD
CY2012Q2	us-gaap	Restructuring Charges RestructuringCharges	600000	USD
CY2011Q2	us-gaap	Legal Fees LegalFees	1200000	USD
	us-gaap	Legal Fees LegalFees	4700000	USD
	us-gaap	Legal Fees LegalFees	1200000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1100000	USD
CY2012Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	800000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1200000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	600000	USD
CY2011Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1200000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	2700000	USD
CY2012Q2	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	3600000	USD
	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	7000000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
CY2011Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	300000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	3600000	USD
CY2011Q2	us-gaap	Interest Expense InterestExpense	1600000	USD
	us-gaap	Interest Expense InterestExpense	7100000	USD
	us-gaap	Interest Expense InterestExpense	3100000	USD
CY2012Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	700000	USD
CY2011Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3800000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2300000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6700000	USD
CY2011Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-500000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1200000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1300000	USD
CY2012Q2	brkr	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-2800000	USD
	brkr	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-10300000	USD
	brkr	Operating Segments Number OperatingSegmentsNumber	5	segment
	brkr	Number Of Divisions NumberOfDivisions	5	division
CY2012Q2	us-gaap	Revenues From Transactions With Other Operating Segments Of Same Entity RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity	-2300000	USD
CY2011Q2	us-gaap	Revenues From Transactions With Other Operating Segments Of Same Entity RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity	-4800000	USD
	us-gaap	Revenues From Transactions With Other Operating Segments Of Same Entity RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity	-4800000	USD
	us-gaap	Revenues From Transactions With Other Operating Segments Of Same Entity RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity	-7600000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	22100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	56500000	USD
CY2011Q2	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	700000	USD

Files In Submission

Name	View Source	Status
0001104659-12-056040-index-headers.html	Edgar Link	pending
0001104659-12-056040-index.html	Edgar Link	pending
0001104659-12-056040.txt	Edgar Link	pending
0001104659-12-056040-xbrl.zip	Edgar Link	pending
a12-13801_110q.htm	Edgar Link	pending
a12-13801_1ex10d1.htm	Edgar Link	pending
a12-13801_1ex10d2.htm	Edgar Link	pending
a12-13801_1ex31d1.htm	Edgar Link	pending
a12-13801_1ex31d2.htm	Edgar Link	pending
a12-13801_1ex32d1.htm	Edgar Link	pending
brkr-20120630.xml	Edgar Link	completed
brkr-20120630.xsd	Edgar Link	pending
brkr-20120630_cal.xml	Edgar Link	unprocessable
brkr-20120630_def.xml	Edgar Link	unprocessable
brkr-20120630_lab.xml	Edgar Link	unprocessable
brkr-20120630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g138011kci001.jpg	Edgar Link	pending
g138011kci002.jpg	Edgar Link	pending
g138011kei001.jpg	Edgar Link	pending
g138011kei002.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BRKR
BRUKER CORP Stock $brkr

2012 Q2 Form 10-Q Financial Statement

#000110465912056040 Filed on August 09, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRKR BRUKER CORP Stock $brkr

2012 Q2 Form 10-Q Financial Statement

#000110465912056040 Filed on August 09, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRKR
BRUKER CORP Stock $brkr